NRG Therapeutics has been awarded a non-dilutive grant from Target ALS Foundation to support its discovery programme for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or motor neurone disease. It is one of five recipients of the 2024 In Vivo Target Validation grants… Read More
The US Parkinson’s Foundation has invested nearly $3 million for 33 grants to accelerate Parkinson’s disease (PD) research. The research grants will fund scientists conducting studies across various aspects of PD to bring forward new therapies, treatments, and ultimately a cure for the disease. Read More
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and innovation to advance solutions that are accessible and affordable to… Read More
Myeloma Patients Europe (MPE) has launched a new online tool to facilitate the search of clinical trials in myeloma. The Myeloma and AL Amyloidosis European Clinical Trial Navigator is designed to help patients find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple… Read More
Swedish company IRLAB Therapeutics has been awarded funding of over $2 million from The Michael J Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to conduct a Phase I clinical study of IRL757, a drug candidate in development as a novel treatment of… Read More
Today is #WearAHatDay created by Brain Tumour Research to raise awareness and funds for research into finding treatments for brain cancer. Brain Tumour Research encourages people to “look super for science and help research breakthroughs happen”. Over the last ten years, Wear A Hat Day events have raised more than… Read More
Carey Rooks, Head of Brand and Communications at SPT Labtech, will be running the London Marathon on April 23, 2023 to raise money for Sue Ryder. “Why, oh why?! so many people ask us when we tell them we’re taking part in the London Marathon,” she… Read More
Cyclica has received a grant from the Bill & Melinda Gates Foundation to apply its AI-enabled drug discovery platform to new therapeutic options for multiple low-data biological targets. The end goal is to expand the range of accessible non-hormonal contraceptive choices for women in developing countries. … Read More
